Miglustat Dipharma 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
IB/0017/G 
This was an application for a group of variations. 
25/07/2023 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
batch control/testing takes place 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
period/storage period - Extension or introduction of a 
re-test period/storage period supported by real time 
data 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
IB/0016 
B.II.e.1.z - Change in immediate packaging of the 
25/07/2023 
finished product - Other variation 
IB/0018/G 
This was an application for a group of variations. 
21/06/2023 
SmPC, 
Labelling and 
PL 
SmPC 
B.II.b.4.a - Change in the batch size (including batch 
size ranges) of the finished product - Up to 10-fold 
compared to the originally approved batch size 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
life of the finished product - As packaged for sale 
(supported by real time data) 
T/0015 
Transfer of Marketing Authorisation 
19/12/2022 
13/01/2023 
SmPC, 
Labelling and 
Page 2/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0014 
C.I.2.a - Change in the SPC, Labelling or PL of a 
04/11/2022 
13/01/2023 
SmPC and PL 
PL 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
IA/0013/G 
This was an application for a group of variations. 
27/07/2022 
n/a 
B.I.a.4.b - Change to in-process tests or limits 
applied during the manufacture of the AS - Addition 
of a new in-process test and limits 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
IB/0012 
B.I.a.2.e - Changes in the manufacturing process of 
26/07/2022 
n/a 
the AS - Minor change to the restricted part of an 
ASMF 
IA/0011/G 
This was an application for a group of variations. 
24/06/2022 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
Page 3/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IA/0010 
B.I.b.2.a - Change in test procedure for AS or 
06/04/2022 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0008 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
29/06/2021 
22/07/2022 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IAIN/0009 
B.II.b.1.a - Replacement or addition of a 
07/06/2021 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IA/0007/G 
This was an application for a group of variations. 
07/12/2020 
n/a 
B.III.1.b.4 - Submission of a new/updated or 
deletion of Ph. Eur. TSE Certificate of Suitability - 
Deletion of certificates (in case multiple certificates 
exist per material) 
B.III.1.b.4 - Submission of a new/updated or 
deletion of Ph. Eur. TSE Certificate of Suitability - 
Deletion of certificates (in case multiple certificates 
exist per material) 
B.III.1.b.3 - Submission of a new/updated or 
deletion of Ph. Eur. TSE Certificate of Suitability - 
Updated certificate from an already approved 
Page 4/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
manufacturer 
B.III.1.b.3 - Submission of a new/updated or 
deletion of Ph. Eur. TSE Certificate of Suitability - 
Updated certificate from an already approved 
manufacturer 
B.III.1.b.3 - Submission of a new/updated or 
deletion of Ph. Eur. TSE Certificate of Suitability - 
Updated certificate from an already approved 
manufacturer 
IB/0006 
B.II.b.3.z - Change in the manufacturing process of 
01/09/2020 
n/a 
the finished or intermediate product - Other variation 
IB/0005 
C.I.z - Changes (Safety/Efficacy) of Human and 
07/08/2020 
n/a 
Veterinary Medicinal Products - Other variation 
IA/0004 
B.I.b.1.c - Change in the specification parameters 
11/05/2020 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
IA/0003 
B.II.e.4.a - Change in shape or dimensions of the 
13/12/2019 
09/12/2020 
SmPC, 
container or closure (immediate packaging) - Non-
sterile medicinal products 
Labelling and 
PL 
IB/0002 
C.I.2.a - Change in the SPC, Labelling or PL of a 
28/03/2019 
17/04/2019 
SmPC and PL 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
Page 5/6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the MAH 
IAIN/0001 
B.II.b.1.a - Replacement or addition of a 
21/03/2019 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
Page 6/6 
 
 
 
 
 
 
 
 
 
 
